Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 2/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19219791 | 0.96 | ALDH1A1 (0.38) | ALDH1A1CNR2CNR1HTTL3MBTL1 | |
| SCHEMBL19940160 | 0.89 | ALDH1A1 (0.37) | ALDH1A1CNR2CNR1HTTL3MBTL1 | |
| SCHEMBL21864682 | 0.77 | MTNR1A (0.39) | ALDH1A1CNR2CNR1HTTL3MBTL1 | |
| SCHEMBL11947670 | 0.77 | MTNR1A (0.39) | ALDH1A1CNR2CNR1HTTL3MBTL1 | |
| SCHEMBL16284392 | 0.77 | MTNR1A (0.39) | ALDH1A1CNR2CNR1HTTL3MBTL1 | |
| SCHEMBL14295932 | 0.77 | MTNR1A (0.39) | ALDH1A1CNR2CNR1HTTL3MBTL1 | |
| SCHEMBL85885 | 0.77 | MTNR1A (0.39) | ALDH1A1CNR2CNR1HTTL3MBTL1 | |
| SCHEMBL10288012 | 0.74 | CYP3A4 (0.43) | ALDH1A1HTTL3MBTL1HPGDKDM4E | |
| SCHEMBL10288013 | 0.73 | MEN1 (0.40) | ALDH1A1HTTHPGDKDM4ECYP3A4 | |
| SCHEMBL19940163 | 0.71 | CNR2 (0.44) | ALDH1A1CNR2CNR1HTTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10206894-B2 | Compounds for use in treatment of mucositis | INNOVATION PHARMACEUTICALS INC. (US) | 2019-02-19 | — | — | US | disclosed |
| US-20180064664-A1 | Compounds For Use In Treatment of Mucositis | POLYMEDIX, INC. | 2018-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10206894-B2 | Compounds for use in treatment of mucositis | MUC1, FUT6, SI | ALDH1A1 899/4885CNR2 3195/4885CNR1 3769/4885 |
| US-20180064664-A1 | Compounds For Use In Treatment of Mucositis | MUC1, FUT6, SI | ALDH1A1 899/4885CNR2 3195/4885CNR1 3769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.